共 50 条
A phase 2 study of alrizomadlin, a novel MDM2/p53 inhibitor, in combination with pembrolizumab for treatment of patients with malignant peripheral nerve sheath tumor (MPNST)
被引:0
|作者:
Somaiah, Neeta
Van Tine, Brian Andrew
Chmielowski, Bartosz
Drabick, Joseph J.
Chawla, Sant P.
McKean, Meredith
Spira, Alexander I.
O'Byrne, Kenneth John
Foresto, Steven A.
Movva, Sujana
Kim, AeRang
Gastman, Brian
Pressey, Joseph Gerald
Paudyal, Ben
De, Asit
Winkler, Robert E.
Li, Mingyu
Ahmad, Mohammad
Yang, Dajun
Zhai, Yifan
机构:
[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[2] Washington Univ St Louis, St Louis, MO USA
[3] Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90024 USA
[4] Penn State Canc Inst, Hershey, PA USA
[5] Sarcoma Oncol Res Ctr, Santa Monica, CA USA
[6] Tennessee Oncol, Sarah Cannon Res Inst, Nashville, TN USA
[7] Virginia Canc Specialists, Fairfax, VA USA
[8] Princess Alexandra Hosp, Brisbane, Qld, Australia
[9] Queensland Univ Technol, Brisbane, Qld, Australia
[10] Queensland Childrens Hosp, Brisbane, Qld, Australia
[11] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA
[12] Childrens Natl Med Ctr, Washington, DC 20010 USA
[13] Cleveland Clin, Lerner Coll Med, Cleveland, OH 44106 USA
[14] Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH 45229 USA
[15] Ascentage Pharma Grp Inc, Rockville, MD USA
[16] Ascentage Pharma Suzhou Co Ltd, Suzhou, Peoples R China
[17] Sun Yat Sen Univ, Ctr Canc, Collaborat Innovat Ctr Canc Med, State Key Lab Oncol South China, Guangzhou, Peoples R China
关键词:
D O I:
暂无
中图分类号:
R73 [肿瘤学];
学科分类号:
100214 ;
摘要:
e14627
引用
收藏
页数:1
相关论文